Thomas Longerich
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 51
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Liver physiology and pathology 13
-
- Ubiquitin and proteasome pathways 8
- Co-authors
- Peter Schirmacher (86 shared papers)Kai Breuhahn (20 shared papers)Lars Zender (10 shared papers)Robert Geffers (11 shared papers)Christian Trautwein (14 shared papers)Frank Tacke (12 shared papers)Tetyana Yevsa (3 shared papers)Volker Ehemann (5 shared papers)
- Journals
- Hepatology (21 papers)Journal of Hepatology (18 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (6 papers)Scientific Reports (5 papers)Gut (5 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Thomas Longerich
204 papers receiving 7.7k citations
Thomas Longerich's Hit Papers
Peers
Comparison fields: 5 of 141
- Hepatology 1.4k
- Cancer Research 1.6k
- Epidemiology 1.6k
- Oncology 1.1k
- Molecular Biology 3.0k
Countries citing papers authored by Thomas Longerich
This map shows the geographic impact of Thomas Longerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Longerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Longerich more than expected).
Fields of papers citing papers by Thomas Longerich
This network shows the impact of papers produced by Thomas Longerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Longerich. The network helps show where Thomas Longerich may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Longerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression Hit paper breakdown → | 2016 | 456 |
| 2 | Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis Hit paper breakdown → | 2017 | 425 |
| 3 | 2006 | 354 | |
| 4 | 2006 | 318 | |
| 5 | 2014 | 215 | |
| 6 | 2011 | 211 | |
| 7 | 2013 | 205 | |
| 8 | 2016 | 204 | |
| 9 | Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade Hit paper breakdown → | 2023 | 190 |
| 10 | 2018 | 190 | |
| 11 | 2007 | 160 | |
| 12 | 2014 | 154 | |
| 13 | 2009 | 129 | |
| 14 | 2009 | 129 | |
| 15 | 2012 | 125 | |
| 16 | 2015 | 117 | |
| 17 | 2020 | 116 | |
| 18 | 2010 | 116 | |
| 19 | 2012 | 109 | |
| 20 | 2020 | 107 |
About Thomas Longerich
Thomas Longerich is a scholar working on Hepatology, Molecular Biology, Cancer Research, Epidemiology and Surgery, having authored 206 papers that have together received 7.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Liver physiology and pathology (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Cancer Genomics and Diagnostics (11 papers), Cancer, Hypoxia, and Metabolism (9 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Hepatology (1.4k citations), Cancer Research (1.6k citations), Epidemiology (1.6k citations), Oncology (1.1k citations) and Molecular Biology (3.0k citations). Thomas Longerich has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Peter Schirmacher, Kai Breuhahn, Lars Zender, Robert Geffers, Christian Trautwein, Frank Tacke, Tetyana Yevsa, Volker Ehemann, Tom Luedde and Tim F. Greten. Their work appears in journals such as Hepatology, Journal of Hepatology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Scientific Reports and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.